Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
- Blood donor screening is now a reporting option for antibody screening results. This change covers the use of HLA testing in blood centers/hospital laboratories for the purpose of donor qualification.
- Three 0.25‑mL plasma specimens; must be ordered in conjunction with Survey MX1B or MX1C
Shipment A: January 28
Shipment B: May 19
Shipment C: October 20